Ellevest, Inc. Ptc Therapeutics, Inc. Transaction History

Ellevest, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$41.85 - $53.85 $41 - $53	1 New	1 $0
Q2 2022 Jul 18, 2022	SELL	$25.6 - $45.23 $281 - $497	-11 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$33.33 - $44.6 $4,932 - $6,600	-148 Reduced 93.08%	11 $0
Q4 2021 Jan 24, 2022	BUY	$35.36 - $41.86 $35 - $41	1 Added 0.63%	159 $6,000
Q3 2021 Oct 19, 2021	BUY	$37.01 - $44.74 $4,404 - $5,324	119 Added 305.13%	158 $6,000
Q2 2021 Jul 13, 2021	SELL	$37.95 - $49.37 $30,701 - $39,940	-809 Reduced 95.4%	39 $2,000
Q1 2021 May 03, 2021	BUY	$46.8 - $68.92 $33,040 - $48,657	706 Added 497.18%	848 $40,000
Q4 2020 Feb 04, 2021	BUY	$47.96 - $67.64 $3,165 - $4,464	66 Added 86.84%	142 $9,000
Q3 2020 Oct 26, 2020	BUY	$45.41 - $57.07 $1,634 - $2,054	36 Added 90.0%	76 $4,000
Q2 2020 Jul 06, 2020	BUY	$42.56 - $54.98 $468 - $604	11 Added 37.93%	40 $2,000
Q1 2020 Apr 13, 2020	BUY	$32.37 - $59.36 $291 - $534	9 Added 45.0%	29 $1,000
Q4 2019 Feb 05, 2020	BUY	$32.22 - $50.07 $644 - $1,001	20 New	20 $1,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.